Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 11/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | KDR | P35968 | 3/20 | 0.55 |
| ▸ | ABL1 | P00519 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.54 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | TEK | Q02763 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxfendazole SCHEMBL29409244 | 1.00 | LMNA (0.55) | LMNACYP1A2HIF1AALDH1A1KDR | |
| Oxfendazole SCHEMBL27586080 | 0.99 | LMNA (0.54) | LMNACYP1A2HIF1AALDH1A1KDR | |
| Oxfendazole SCHEMBL28641495 | 0.94 | LMNA (0.50) | LMNACYP1A2HIF1AALDH1A1KDR | |
| Oxfendazole SCHEMBL1498223 | 0.91 | LMNA (0.47) | LMNACYP1A2HIF1AALDH1A1KDR | |
| Oxfendazole SCHEMBL9370016 | 0.91 | LMNA (0.67) | LMNACYP1A2HIF1AALDH1A1KDR | |
| Oxfendazole SCHEMBL9818561 | 0.91 | LMNA (0.64) | LMNACYP1A2HIF1AALDH1A1KDR | |
| Oxfendazole SCHEMBL29351297 | 0.91 | LMNA (0.64) | LMNACYP1A2HIF1AALDH1A1KDR | |
| SCHEMBL11666743 | 0.89 | LMNA (0.46) | LMNACYP1A2HIF1AALDH1A1KDR | |
| SCHEMBL11666872 | 0.89 | LMNA (0.50) | LMNACYP1A2HIF1AALDH1A1KDR | |
| SCHEMBL11663674 | 0.89 | RAB9A (0.53) | LMNACYP1A2HIF1AALDH1A1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6356 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115925637-B | Oxfendazole hapten and artificial antigen as well as preparation methods and application thereof | 北京维德维康生物技术有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12582717-B2 | Protein based excipient for active pharmaceutical ingredients | DISPERSOME IP APS (NL) | 2026-03-24 | — | — | US | claimed |
| US-12496374-B2 | Deodorizer composition, absorbing body, and absorbent article | SUMITOMO SEIKA CHEMICALS CO, LTD. (JP) | 2025-12-16 | — | — | US | claimed |
| US-20250352518-A1 | A BENZIMIDAZOLE COMPOUND WITH ANTIHELMINTHIC ACTIVITY FOR USE IN REVERSING, ARRESTING OR SLOWING DOWN CELLULAR AGEING IN A VERTEBRATE SUBJECT | RAVAN BIO LIMITED (GB) | 2025-11-20 | — | — | US | claimed |
| US-20250333775-A1 | DIAGNOSTIC TEST AND THERAPY FOR PATIENTS WITH AUTO-BREWERY SYNDROME | UNIV CALIFORNIA (US) | 2025-10-30 | — | — | US | claimed |
| US-20250276967-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | SIGNAL PHARMACEUTICALS, LLC | 2025-09-04 | — | — | US | claimed |
| EP-4586826-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | In the Bowl Animal Health, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| CN-120157447-A | Cattle and sheep licking brick taking magnesium phosphate cement as binding material and preparation method thereof | 南京航空航天大学 | 2025-06-17 | — | — | CN | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-120018779-A | Feed and method for controlling infection of central filarial in mammals | 碗中动物健康公司 | 2025-05-16 | — | — | CN | claimed |
| EP-0125654-A2 | Process for the preparation of especially pharmacologically active compounds containing a sulfoxide group | ZAMBON S.p.A. (IT) | 1984-11-21 | — | — | EP | claimed |
| EP-0060810-B1 | ANTHELMINTICS | CIBA-GEIGY AG (CH) | 1984-10-17 | — | — | EP | claimed |
| EP-0059074-B1 | ANTHELMINTIC COMPOSITION AND THE USE THEREOF | SANKYO COMPANY LIMITED (JP) | 1984-10-10 | — | — | EP | claimed |
| US-4468390-A | Anthelmintic composition and the use thereof | SANKYO COMPANY, LIMITED (JP) | 1984-08-28 | — | — | US | claimed |
| EP-0090368-A1 | Anthelmintic preparations | HOECHST UK LIMITED (GB) | 1983-10-05 | — | — | EP | claimed |
| EP-0059074-A1 | Anthelmintic composition and the use thereof | SANKYO COMPANY LIMITED (JP) | 1982-09-01 | — | — | EP | claimed |
| US-4251506-A | Controlled-release compositions for administration of therapeutic agents to ruminants | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1981-02-17 | — | — | US | claimed |
| US-4166858-A | CONCURRENT OR SEQUENTIAL ADMINISTRATION OF AN ETHER, SUCH AS DIAMPENETHIDE, AND A POTENTIATING BENZIMIDAZOLE; VERTERINARY MEDICINE | BURROUGHS WELLCOME CO. (US) | 1979-09-04 | — | — | US | claimed |
| US-4159337-A | VERTERINARY MEDICINE | BURROUGHS WELLCOME CO. (US) | 1979-06-26 | — | — | US | claimed |
| US-4080461-A | PESTICIDES, FUNGICIDES | SYNTEX (U.S.A.) INC. (US) | 1978-03-21 | — | — | US | claimed |